LONDON (Alliance News) - Medical retinal imaging company Optos PLC Tuesday said the first shipments of its California ultra-widefield imaging platform product have started.
"We have begun shipments of our California devices as planned, demonstrating a tremendous company-wide achievement. We have utilised the latest design, manufacturing and software technologies in California and continued our investment in clinical research to support this product launch," said Roy Davis, Optos' chief executive.
Optos shares were untraded Tuesday, having last traded at 344.00 pence.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.


(Alliance News) - Croda International PLC on Monday said Finance Director Jez Maiden will retire next year after eight years in the role and be replac...


UK stocks touched a new intraday record on Friday before slipping into the red, as investors treaded carefully on another busy day for corporate earni...


Retinal imaging company Optos has recommended a £259m cash offer from Japanese giant Nikon. The 340p-a-share cash offer values the London-listed compa...